Cannabinoid tetrad
The cannabinoid tetrad test screens pharmacological compounds that induce cannabinoid receptor-mediated effects. This preclinical model includes a series of four tests, i.e., behavioral components, which are spontaneous activity, catalepsy, hypothermia and analgesia.